Last update 22 Dec 2024

SA55/SA58

Overview

Basic Info

Drug Type
Antibody
Synonyms
BD55-5840/BD55-5514, 新冠中和抗体SA55
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein modulators(SARS-CoV-2 S protein modulators)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication-
Originator Organization
Peking UniversityPeking University
Active Organization
Peking UniversityPeking UniversityBeijing Kexing Zhongwei Biotech Co. Ltd.Beijing Kexing Zhongwei Biotech Co. Ltd.Shandong Kexing Bioproducts Co., Ltd.Shandong Kexing Bioproducts Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with SA55/SA58
NCT06042764 / RecruitingPhase 2
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of Novel Coronavirus Broad-spectrum Neutralizing Antibody SA55 Injection in the Treatment of Mild/Moderate COVID-19 Patients
NCT06050460 / RecruitingPhase 1
A Phase I Clinical Trial to Evaluate the Safety, Tolerance and Pharmacokinetics of A Broad-Spectrum Neutralizing Antibodies SA55 Injection of COVID-19 in Healthy Adults
NCT06048393 / RecruitingPhase 1
A Phase I Clinical Study of Novel Coronavirus Broad-spectrum Neutralizing Antibody SA55 Nasal Spray in Healthy People
100 Clinical Results associated with SA55/SA58
Login to view more data
100 Translational Medicine associated with SA55/SA58
Login to view more data
100 Patents (Medical) associated with SA55/SA58
Login to view more data
100 Deals associated with SA55/SA58
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 1
CN
Beijing Kexing Zhongwei Biotech Co. Ltd.Beijing Kexing Zhongwei Biotech Co. Ltd.
31 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05667714 (Pubmed)
Not Applicable
COVID-19
-
gyxdlsbluq(aatnygjskl) = hajaqnskap wzefunozhd (lelksszdtu )
View more
Positive
08 May 2023
Placebo
gyxdlsbluq(aatnygjskl) = kvxmfavxlt wzefunozhd (lelksszdtu )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free